Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported flat fiscal fourth quarter revenues and a 1 percent increase in fiscal year 2016 revenues.

The results were consistent with preliminary earnings announced last month that sent the firm's stock tumbling.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.